News

Castellum, Inc. Achieves Historic Financial Milestone with Q3 Net Income

Castellum, Inc. Achieves Historic Financial Milestone with Q3 Net Income

Castellum, Inc. Achieves Significant Financial Milestone

Castellum, Inc. (NYSE-American: CTM) has marked a historical turning point in its financial journey with its recently announced third quarter results for 2025, showcasing its first-ever GAAP net income. This milestone is not only a significant achievement but also a testament to the company's diligent efforts in enhancing its financial health and operational efficiency.

Record-Breaking Revenue in Q3 2025

For the third quarter of 2025, Castellum achieved outstanding revenue of $14.6 million. This figure reflects a notable increase compared to $14.0 million reported in the previous quarter and a significant rise from $11.6 million in the same quarter last year. The company's sustained commitment to organic growth has led to its third consecutive quarter of year-over-year revenue increases, solidifying its position in the cybersecurity and defense sectors.

Strong Operating Performance

The operating profit for Q3 2025 reached $0.4 million, a remarkable recovery from an operating loss of $(0.4) million just a quarter earlier and a staggering improvement from a $(7.3) million loss reported in Q3 2024. These results reflect Castellum's ongoing focus on cost management and operational efficiency, even when accounting for non-cash and one-time charges in the results. When adjusted for these factors, the company generated an impressive $1.1 million in adjusted EBITDA.

Substantial Cash Reserves and Debt Reduction

Ending the quarter with a record cash balance of $17.8 million, up from $14.7 million at the end of Q2 2025, Castellum demonstrates a solid commitment to liquidity and prudent fiscal management. In addition, the company successfully reduced its total debt to $2.4 million this quarter, further enhancing its balance sheet and financial stability. This ongoing debt reduction is critical for supporting future growth and operational flexibility.

Leadership Insights on Performance and Strategy

David Bell, Chief Financial Officer, expressed pride in the company’s performance, stating, "Our continued discipline in operating performance and cash management has resulted in our best performance and balance sheet strength to date, all of which prepares Castellum for additional investment in our growth." Furthermore, Glen Ives, Chief Executive Officer, remarked on the exceptional results, emphasizing the importance of focusing on long-term growth, strategic investments, and people that drive the organization forward.

Outlook and Future Plans

Castellum's commitment to growth remains resolute. The company plans to continue investing in its organic growth strategies, including maximizing prime contract wins and exploring meaningful mergers and acquisitions. This strategic approach is aimed at developing robust products, solutions, and intellectual property, which in turn will enhance shareholder value and position Castellum as a leader in its industry.

Frequently Asked Questions

What were Castellum's revenue figures for Q3 2025?

Castellum reported revenue of $14.6 million for the third quarter of 2025, showing a year-over-year growth.

How much debt does Castellum currently have?

As of Q3 2025, Castellum has successfully reduced its total debt to $2.4 million.

What does GAAP net income mean for Castellum?

This is the first time Castellum has reported a positive GAAP net income, marking a significant milestone for the company.

What are Castellum's future growth strategies?

Castellum plans to focus on organic growth through contract wins and explore mergers and acquisition opportunities to enhance its market position.

Who leads Castellum, Inc.?

The company is led by Glen Ives as the Chief Executive Officer and David Bell as the Chief Financial Officer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 51

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 197

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
AVANT BIO Beef Up Team with Heavyweights Lio, Vanek

Updated Category News Views 122

AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...

Continue Reading
Massive $1B Jobs Initiative Fights AI Automation Impact

Updated Category News Views 40

Initiative Tackles Economic Shifts Head-On AI and automation are turning the job market upside down, and more than 20 foundations and philanthropies are throwing their weight behind a $1 billion initiative called All In For Jobs. Their aim? Connect half a million Americans to stable, decent-paying jobs and prepare communities to face the daunting transition imposed by...

Continue Reading
Natural Field Reinvents Supplement Delivery at SupplySide

Updated Category News Views 29

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Continue Reading
Touchmark's Q3 Bonanza: Income Leaps 39%, Stock Repurchase

Updated Category News Views 54

Ever seen a bank juggle financials like a street performer with flaming torches? That's Touchmark Bancshares for you this quarter. This Georgia-based community bank just released their third quarter 2026 results, and it seems they've not only mastered performance but also pranced around market risks effortlessly, much to the delight of investors. Breaking Down the Numbers...

Continue Reading
Parloa's AI Agents Boost SAP Customer Experience

Updated Category News Views 145

AI Meets SAP in Customer Experience Revolution Alright, let's cut through the tech chatter. Parloa’s Agent Management Platform has hitched its wagon to SAP as a spiffy Solution Extension. This isn't just tech fluff—it’s a big step for scratching that CX itch companies have. By merging Parloa's AI magic with SAP's existing mojo, businesses get a toolset to enhance...

Continue Reading
Innventure Faces Legal Scrutiny Over DarkNX Debacle

Updated Category News Views 70

Innventure’s Market Tumult: Unraveling the Drama Talk about a mess. Innventure Inc. (NASDAQ: INV) investors are likely feeling a sting sharper than a bee that's lost its hive after a painful 55% stock crash back in August 2026. The culprit? A scuttled project involving a shadowy partner, DarkNX, and a lot of questions about who knew what and when. A Puzzling...

Continue Reading
GrOwnValve's Personalized Valves Pass Safety Milestone

Updated Category News Views 58

Pioneering Success in Personalized Valve Study GrOwnValve GmbH just hit a big milestone that's caught my attention. Their first-in-human heart valve study wrapped up its six-month run with no prosthesis-related mishaps. Yeah, zero misfires. For five whole patients who've been through the wringer, things held steady. This Berlin startup’s got guts, testing tech that...

Continue Reading
Fair Play in Focus: SYNA, CSR, VCTR, EFSI Deals Scrutinized

Updated Category News Views 77

The Corporate Buzz: Deals Under the Microscope Riding the rollercoaster of mergers and acquisitions ain't new in the stock market realm. But when the stakes seem one-sided, alarms start ringing. Halper Sadeh LLC, a firm that cuts its teeth on this kind of corporate sleuthing, is all hands on deck probing a slew of big deals involving Synaptics (NASDAQ:SYNA), Centerspace...

Continue Reading

Top 5 Most Recently Viewed Articles

Perspective Therapeutics Enhances [212Pb]VMT01 for Melanoma Treatment

Updated Category News Views 63

Overview of [212Pb]VMT01 Developments [212Pb]VMT01 has emerged as a promising candidate in the realm of radiopharmaceutical therapy. Recent initial results from the Phase 1/2a trial highlight its safety and efficacy, particularly in patients with advanced melanoma. Significantly, the trial showed that at doses of 3.0 mCi and 5.0 mCi, patients experienced no dose-limiting...

Continue Reading
Revolutionizing Visualization: STC AI's Impact on Presentations

Updated Category News Views 231

Transforming Data Visualization with STC AI In today's fast-paced world, where data is central to decision-making, being able to convey information in a clear and engaging manner is essential. Unfortunately, many professionals struggle with this crucial skill. Enter STC AI, a revolutionary free PowerPoint add-in created by Storytelling with Charts. This powerful tool is...

Continue Reading
The Metals Company (TMC): A Promising Project Unveiled

Updated Category News Views 196

Understanding The Metals Company's Recent Developments The Metals Company Inc shares are seeing an upward trend following notable announcements. Two economic studies have been released, indicating a staggering total project value of $23.6 billion and revealing mineral reserves that are pivotal for their polymetallic nodule project. The Polymetallic Nodule Project Overview...

Continue Reading
Exploring the Growth and Trends in the Global Chip Manufacturing Sector

Updated Category News Views 235

Overview of Chip Manufacturing Market Dynamics The global chip manufacturing market is experiencing remarkable growth, driven by technological advancements and an increased demand for semiconductors across versatile industries. With an estimated value of approximately USD 500 billion, it is expected to double, reaching nearly USD 1 trillion by 2034, indicating a solid...

Continue Reading
Sempra Earns Spot as a Top Global Company for 2024 Recognition

Updated Category News Views 168

Sempra Celebrated as One of the World's Best Companies Sempra (NYSE: SRE) has proudly landed a spot on TIME Magazine's prestigious list of the World's Best Companies for the year 2024. This esteemed recognition, determined in collaboration with Statista Inc., highlights Sempra's place among top global companies based on three vital pillars: employee satisfaction, revenue...

Continue Reading